Preclinical CROs in South Korea

8 contract research organizations in our directory list a site in South Korea. 7 report GLP capability and 2 report AAALAC accreditation. Compare services, species and accreditations below, and contact labs directly from their profiles.

8 CROs 7 GLP 2 AAALAC

Preclinical research in South Korea

Among the CROs listed in South Korea, the most common services are GLP Toxicology, Safety Pharmacology, Repeat-Dose Toxicity and In Vivo Efficacy. The species they most often work with are Mouse, Rat and Dog.

Showing 8 CROs with a site in South Korea. Order rotates daily so no lab is permanently listed first.

HLB bioStep (formerly Knotus)

Incheon GLP

Korean non-clinical CRO focused on efficacy testing of new drug candidates, with research facilities in Songdo, Incheon.

In Vivo Efficacy Inflammation Models Toxicology Mouse Rat

K-Prime Research (BTT Group)

Osong GLP

Korean nonhuman primate CRO in the Biotoxtech group with GLP repeat-dose toxicity and cardiovascular safety pharmacology in NHPs, plus NHP inhalation studies.

Cardiovascular Safety GLP Toxicology Inhalation Toxicity Repeat-Dose Toxicity Safety Pharmacology Cynomolgus monkey Non-human Primate

DT&CRO

Yongin GLP

Korean CRO covering GLP toxicity, PK and efficacy studies through to clinical trials for drugs, devices and other products.

Bioanalysis GLP Toxicology In Vivo Efficacy Medical Device Testing Pharmacokinetics Dog Mouse Rabbit Rat

Biotoxtech

Cheongju GLP AAALAC

Korean non-clinical CRO offering IND and NDA-enabling GLP toxicology, including general, reproductive and genetic toxicity, carcinogenicity and safety pharmacology, with NHP capacity through its group companies.

Carcinogenicity Studies Genetic Toxicology GLP Toxicology Repeat-Dose Toxicity Reproductive Toxicity Dog Mouse Non-human Primate Rabbit

Korea Institute of Toxicology (KIT)

Daejeon GLP

Government-funded Korean research institute providing GLP nonclinical safety studies, including inhalation toxicology, safety pharmacology and reproductive toxicity.

GLP Toxicology Inhalation Toxicity Repeat-Dose Toxicity Reproductive Toxicity Safety Pharmacology Dog Mouse Non-human Primate Rat

QuBEST Bio

KR

Korean nonclinical CRO providing early PK, TK and bioanalytical method development and sample analysis.

Bioanalysis In Vivo PK Method Development Toxicokinetics Mouse Rat

Keyfronbio (BTT Group)

KR GLP

Korean nonclinical pharmacology CRO in the Biotoxtech group offering efficacy studies, PCR-based biodistribution for cell and gene therapies, and GLP bioanalysis.

Bioanalysis Biodistribution Gene Therapy Studies In Vivo Efficacy Mouse Rat

CorestemChemon (ChemOn)

Yongin GLP AAALAC

South Korea's first private non-clinical CRO, providing GLP toxicity, safety pharmacology, pharmacokinetic and efficacy studies for drugs, chemicals and biologics.

GLP Toxicology In Vivo Efficacy Pharmacokinetics Repeat-Dose Toxicity Safety Pharmacology Dog Mouse Rabbit Rat

Questions to ask a CRO in South Korea

  • Will the study run at the site in South Korea, or could work be moved to another of your facilities?
  • How do you receive test article shipments, and what import permits or customs paperwork do you handle?
  • Can our team visit the facility before the study starts and during critical phases?
  • Which regulators and GLP monitoring authorities have inspected this site, and when?
  • What is your current lead time for our species at this site?

For a full checklist, see our CRO selection guide.